We develop generics with proven
therapeutic efficacy and safety of administration
Analyzing and strategically adapting the portfolio according to medical trends is a priority.
Medicines that are predominantly developed through their own research programs complement the company’s traditional portfolio.
They are intended for the treatment of generic infections of the following classes:
- cardiovascular
- central nervous system
- digestive tract
- anti-inflammatory
- dermatology
- prophylaxis
- increasing quality of life
All medicines can be given by self-medication.
Antibiotice has the necessary know-how to collaborate with partners from all over the world.
We can develop:
- integrated projects
- research and realization of registration dossiers
- conducting bioequivalence studies
- registration of projects with the competent external authorities for marketing purposes
